Literature DB >> 8847553

Interaction between microwave-induced brain hyperthermia and high dose rate radiation in the BT4 An brain glioma in rats.

B K Krossnes1, B C Schem, B Nygaard, O Dahl, O Mella.   

Abstract

The cerebral BT4An glioma model in BD IX rats was used to study the effect of hyperthermia given in combination with radiotherapy (thermoradiotherapy) in the treatment of brain tumours. A single treatment with high dose rate radiation was given to a local brain field. Local brain hyperthermia was given at 42.4 degrees C for 45 min by externally applied microwaves (700 MHz), immediately before radiotherapy (10 Gy). In a pilot study, thermoradiotherapy increased the median life span with 20 days compared to controls, which was significantly better than that observed after radiotherapy alone (7 days). In an extended experiment the corresponding figures for thermoradiotherapy, hyperthermia alone and radiotherapy alone were 12.5, 3.5, and 3.5 days, respectively. Thermoradiotherapy was significantly better than radiotherapy and hyperthermia alone. There was no acute mortality in these experiments. Neurological side-effects were infrequent, of slight degree and reversible. The present study shows that a survival benefit of adding hyperthermia to radiotherapy can be achieved without unacceptable neurological side-effects in an animal glioma model.

Entities:  

Mesh:

Year:  1996        PMID: 8847553     DOI: 10.1007/bf00165476

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  22 in total

1.  Radiation therapy of 9L rat brain tumors.

Authors:  S D Henderson; B F Kimler; R A Morantz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1981-04       Impact factor: 7.038

2.  Radiofrequency hyperthermia for malignant brain tumors: preliminary results of clinical trials.

Authors:  R Tanaka; C H Kim; N Yamada; Y Saito
Journal:  Neurosurgery       Date:  1987-10       Impact factor: 4.654

3.  Iridium-192 brachytherapy in combination with interstitial microwave-induced hyperthermia for malignant glioma.

Authors:  D W Roberts; J W Strohbehn; C T Coughlin; T P Ryan; B E Lyons; E B Douple
Journal:  Appl Neurophysiol       Date:  1987

4.  [Histopathologic changes and tumor cell kinetics after hyperthermia and/or radiation therapy in a rat glioma model: bromodeoxyuridine (BUdR) labelling index].

Authors:  M Tamura; T Tsukahara; H Kunimine; A Zama; Y Tamaki; H Niibe
Journal:  No Shinkei Geka       Date:  1989-06

5.  Normal brain response after interstitial microwave hyperthermia.

Authors:  J R Fike; G T Gobbel; T Satoh; P R Stauffer
Journal:  Int J Hyperthermia       Date:  1991 Sep-Oct       Impact factor: 3.914

6.  Enhancement of ACNU treatment of the BT4An rat glioma by local brain hyperthermia and intra-arterial drug administration.

Authors:  B C Schem; B K Krossnes
Journal:  Eur J Cancer       Date:  1995-10       Impact factor: 9.162

Review 7.  Effect of hyperthermia on the central nervous system: a review.

Authors:  P Sminia; J van der Zee; J Wondergem; J Haveman
Journal:  Int J Hyperthermia       Date:  1994 Jan-Feb       Impact factor: 3.914

8.  Chronic histological effects of ultrasonic hyperthermia on normal feline brain tissue.

Authors:  B E Lyons; W G Obana; J K Borcich; R Kleinman; D Singh; R H Britt
Journal:  Radiat Res       Date:  1986-05       Impact factor: 2.841

Review 9.  The current and potential role of hyperthermia in radiotherapy.

Authors:  J Overgaard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1989-03       Impact factor: 7.038

10.  [Effect of hyperthermia in combination with radiation therapy in a rat glioma model].

Authors:  M Tamura; A Zama; H Kunimine; Y Tamaki; H Niibe
Journal:  No Shinkei Geka       Date:  1988
View more
  1 in total

1.  Effective solitary hyperthermia treatment of malignant glioma using stick type CMC-magnetite. In vivo study.

Authors:  Takanari Ohno; Toshihiko Wakabayashi; Atsuhito Takemura; Jun Yoshida; Akira Ito; Masashige Shinkai; Hiroyuki Honda; Takeshi Kobayashi
Journal:  J Neurooncol       Date:  2002-02       Impact factor: 4.130

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.